O'Malley Pushes FDA Funding, Release Of Clinical Trial Data, Drug Price Policies In Health Care Plan

Democratic presidential candidate Governor Martin O'Malley advocates for additional funding for FDA and the National Institutes of Health and expedited approval of breakthrough treatments, and also calls for the public release of clinical trial data, in his health care plan released on Tuesday (Nov. 24). O'Malley, in his plan, claims it is lack of funding, not safety and efficacy requirements, that is preventing new drugs and medical devices from entering the market. “While the Food and Drug Administration (FDA) is...